Correlation of Microbiome and Metabonomics With IgA Nephropathy
NCT05190848 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2025-03-12
Summary
IgAN is the most prevalent primary glomerulonephritis in China, is characterized by the deposition of IgA1 (particularly, galactose-deficient IgA1) in the glomerular mesangium. Galactosedeficient IgA1, supposed to be produced by Peyer patches in the mucosa-associated lymphoid tissue (MALT), is triggered by exposure to commensal or pathogenic bacteria, involved in the initial step in the pathogenesis of IgAN. Similar to intestinal flora, a disruption in oral flora is closely associated with the occurrence of many malignant tumors and autoimmune diseases. The relationship between oral and throat microflora and the occurrence of IgAN is unclear at present. The aim of the present study was to develop a preliminary model based on mucosa -specific microbes and clinical indicators to facilitate the early diagnosis of IgAN and obtain insights into its treatment.
Conditions
Sponsors & Collaborators
-
Guangdong Provincial People's Hospital
lead OTHER
Principal Investigators
-
Xueqing Yu · Guangdong Provincial People's Hospital
-
Xinling Liang · Guangdong Provincial People's Hospital
-
Zhiming Ye · Guangdong Provincial People's Hospital
Eligibility
- Min Age
- 16 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-05-01
- Primary Completion
- 2024-12-01
- Completion
- 2025-12-01
Countries
- China
Study Locations
More Related Trials
-
Biomarkers for the Progression of IgA Nephropathy
NCT02529722 ·Status: COMPLETED
-
Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis
NCT00004305 ·Status: COMPLETED
-
Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy
NCT00521508 ·Status: COMPLETED ·Phase: NA
-
Immune System Related Kidney Disease
NCT00001979 ·Status: RECRUITING
-
RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)
NCT06926244 ·Status: RECRUITING
-
IgA Nephropathy, Lymphocyte Homing and IgA Class Switch
NCT01775527 ·Status: COMPLETED ·Phase: NA
-
Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN)
NCT07295808 ·Status: RECRUITING ·Phase: NA
-
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
NCT06605378 ·Status: RECRUITING
-
Multicenter Study Evaluating the Performance of the Assay of Anti-hinge Region Antibodies in the Diagnosis of Progressive Forms of IgA Nephropathy
NCT02526966 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System
NCT01063309 ·Status: COMPLETED
-
Key Mechanisms of Abnormal T Cell Activation and Differentiation in IgG4-Related Ophthalmic Disease
NCT06655831 ·Status: NOT_YET_RECRUITING
-
Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis
NCT07010250 ·Status: NOT_YET_RECRUITING
-
Relationship Between Gut Microbiota And Anemia In Patients With Chronic Renal Failure
NCT03220685 ·Status: COMPLETED
-
Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy
NCT05791162 ·Status: RECRUITING ·Phase: NA
-
A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Alcohol Liver Disease
NCT07284862 ·Status: COMPLETED
-
Specific Autoantibody Testing in Patients With Interstitial Lung Disease
NCT01600352 ·Status: COMPLETED
-
Prevalence and Pathological Features of C3 Dominant Glomerulonephritis Among Egyptian Population
NCT06126471 ·Status: RECRUITING
-
Tonsillectomy and Primitive IgA Nephropathy in Children: Strasbourg Cohort and Assessment Practices in Inter North East Region
NCT02829164 ·Status: UNKNOWN
-
The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease Patients
NCT02493101 ·Status: COMPLETED
-
Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study
NCT06350630 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effectiveness of Serum Leucine-rich Alpha-2 Glycoprotein Levels on IBD
NCT04535882 ·Status: RECRUITING
-
Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients
NCT04817553 ·Status: COMPLETED
-
Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
NCT06691529 ·Status: NOT_YET_RECRUITING
-
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT01195987 ·Status: UNKNOWN
-
IgA-positive Versus IgA-negative Immune Complex Vasculitis
NCT01815190 ·Status: UNKNOWN